SCHEMBL6592007

SCHEMBL6592007

O=c1nc(/C=C/c2ccc(-c3ccc(Cl)cc3)o2)cc(C(F)(F)F)[nH]1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSD A5PKW4 1/20 0.84
KMT2A Q03164 8/20 0.82
MEN1 O00255 7/20 0.82
MAPT P10636 6/20 0.82
POLB P06746 5/20 0.82
LMNA P02545 4/20 0.82
HPGD P15428 4/20 0.82
ALDH1A1 P00352 7/20 0.70
KDM4E B2RXH2 7/20 0.70
USP2 O75604 2/20 0.70
CRHBP P24387 1/20 0.70
CRHR2 Q13324 1/20 0.70
L3MBTL1 Q9Y468 1/20 0.70
HTT P42858 3/20 0.61
RECQL P46063 2/20 0.61
TLR9 Q9NR96 1/20 0.61
TNF P01375 3/20 0.58
NOD1 Q9Y239 3/20 0.58
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6592011 1.00 PSD (0.84) PSDKMT2AMEN1MAPTPOLB
SCHEMBL6595722 0.91 PSD (1.00) PSDKMT2AMEN1MAPTPOLB
SCHEMBL6595724 0.91 PSD (1.00) PSDKMT2AMEN1MAPTPOLB
SCHEMBL6592402 0.90 MAPT (1.00) PSDKMT2AMEN1MAPTPOLB
SCHEMBL6592407 0.90 MAPT (1.00) PSDKMT2AMEN1MAPTPOLB
SCHEMBL6596295 0.89 PSD (0.77) PSDKMT2AMEN1MAPTPOLB
SCHEMBL6596299 0.89 PSD (0.77) PSDKMT2AMEN1MAPTPOLB
SCHEMBL6593893 0.89 MEN1 (0.82) PSDKMT2AMEN1MAPTPOLB
SCHEMBL6593887 0.89 MEN1 (0.82) PSDKMT2AMEN1MAPTPOLB
SCHEMBL6593640 0.88 PSD (0.82) PSDKMT2AMEN1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1389461-A1 Pyrimidones with antiviral properties Axxima Pharmaceuticals Aktiengesellschaft (DE) 2004-02-18 EP claimed
EP-1389461-A1 Pyrimidones with antiviral properties Axxima Pharmaceuticals Aktiengesellschaft (DE) 2004-02-18 EP disclosed